Treatment with semaglutide significantly elevated plasma GLP-1 levels in both Bbs5 / and WT mice (Figure 6A), confirming that intervention was effective regardless of genotype
Retatrutide achieved approximately 24 to 28.7% weight loss at its highest dose over 48 to 72 weeks, compared to Mounjaro achieving approximately 20 to 22.5% at its highest dose over 72 weeks
One of the outcomes was speculated to be an increase in skin pigmentation, which lent credence to the hypothesis of MT-II to act as a sunless tanning agent when it is provided to mouse models in modest concentrations every other day
When using any new medicine, its helpful to stay informed with accurate information and speak with medical professionals when questions arise
Semaglutide trials (STEP 1-4) demonstrated 15-22% weight loss over 68 weeks, while tirzepatide (SURMOUNT trials) showed 20-24% weight loss at the highest doses
Lesinurad/Allopurinol (Duzallo) for Gout-Associated Hyperuricemia